PI Industries Limited
Keynote Capitals Ltd
Quarterly Update Q1FY25
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 Aug 2024 | PI Industries |
Keynote Capitals Ltd
|
3396.10 | 4722.00 | 4441.00 (-23.53%) | Target met |
Neutral
|
||||
| 02 Aug 2024 | UPL |
Motilal Oswal
|
759.10 | 550.00 | 537.60 (41.20%) | Target met |
Neutral
|
||||
| 30 Jul 2024 | Sharda Cropchem |
Khambatta Securities
|
868.25 | 676.00 | 557.05 (55.87%) | Target met |
Buy
|
Volumes have started recovering, price devaluation has halted
Khambatta Securities
Sharda Cropchem Limited (SCL) reported solid growth in 1Q FY25 as revenues increased by 23.1% y-o-y to Rs 785.1 crore. A volume growth of 41% y-o-y was driven by strong performance at the agrochemical segment.
|
|||
| 27 Jun 2024 | PI Industries |
Sharekhan
|
3396.10 | 4400.00 | 3819.55 (-11.09%) | Target met |
Buy
|
Acquisition in the fast-growing biologics space
Sharekhan
PI Industries has offered to acquire UK based listed company Plant Health Care Plc (PHC) for a sum of £32.8 million which is in the agriculture biological space. It has experience in protein/peptide technology.
|
|||
| 27 May 2024 | UPL |
Geojit BNP Paribas
|
759.10 | 555.00 | 524.95 (44.60%) | Target met |
Hold
|
||||
| 24 May 2024 | PI Industries |
Keynote Capitals Ltd
|
3396.10 | 4319.00 | 3630.90 (-6.47%) | Target met |
Buy
|
||||
| 23 May 2024 | PI Industries |
Motilal Oswal
|
3396.10 | 4280.00 | 3659.50 (-7.20%) | Target met |
Buy
|
Healthy performance despite a weak domestic business
Motilal Oswal
PI Industries (PI)’s revenue grew 11% YoY in 4QFY24, led by a healthy growth
in the CSM business (up 9% YoY) and incremental revenue from the Pharma business, which was absent in 4QFY23 (revenue mix of ~4% in 4QFY24). |
|||
| 13 May 2024 | UPL |
Motilal Oswal
|
759.10 | 560.00 | 534.10 (42.13%) | Target met |
Neutral
|
Higher rebates and high-cost inventory liquidation hit margin
Motilal Oswal
UPLL reported a weak quarter as revenue declined 15% YoY, primarily due to
lower agrochemical prices (down 15% YoY) and volume decline of 2% YoY. EBITDA margins contracted 450bp YoY largely due to higher rebates (~5% price impact) and liquidation of high-cost inventory, partly offset by an improved product mix and a lower cost of goods sold. |
|||
| 05 Feb 2024 | PI Industries |
Axis Direct
|
3396.10 | 3750.00 | 3281.95 (3.48%) | Target met |
Buy
|
Pick of the Week:05 FEB 2023
Axis Direct
PI Industries strong track record, long-term relationships and ability to innovate new molecules gives us the confidence to value it 27x Sep FY26E resulting to near term TP of Rs 3750, implying an upside of 11% from the CMP.
|
|||
| 31 Oct 2023 | UPL |
Prabhudas Lilladhar
|
759.10 | 550.00 | 540.50 (40.44%) | Target met |
Hold
|
||||
|
more
loading
|
|||||||||||